Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis

Abstract Background Preoperative treatment of anti-vascular endothelial growth factor (VEGF) agents is extensively used in proliferative diabetic retinopathy (PDR), but the molecular mechanism is not fully understood. The objective of this research is to observe change of protein profile induced by...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Chen Zou, Changjing Han, Minjie Zhao, Jingjing Yu, Lin Bai, Yuan Yao, Shuaixin Gao, Hui Cao, Zhi Zheng
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2018-03-01
Serija:	Clinical Proteomics
Teme:	Proteomics Proliferative diabetic retinopathy Ranibizumab
Online dostop:	http://link.springer.com/article/10.1186/s12014-018-9187-z
Oznake:	Označite Brez oznak, prvi označite!